- Reaction score
- 42
S Foote. said:There is no `technical bluff' here Bryan, if you don't understand this you shouldn't get involved in scientific debates!
The second study says:
"Thus suppression of p45, cyclin D2/Cdk-4, and cyclin B1/Cdc-2 expression and/or activities is targeted both by contact inhibition and by TGF-beta 1 and may define common mechanisms through which these negative growth signals are integrated."
So if contact inhibition and TGF-Beta 1 are `using' the same genes, prior contact inhibition in-vivo can change the expression of these genes to then allow an effect of TGF- Beta 1 in-vitro.
No, Stephen, you don't understand what they said. Prior contact inhibition doesn't "change" the expression of those genes to "allow" an effect of TGF-Beta 1 in vitro. They merely said that contact inhibition AND TGF-Beta 1 both affect those same genes. That's completely different from the way you attempted to spin it.
S Foote. said:The study shows that TGF-Beta 1 `actually' prevents cell release `FROM' contact inhibition, so there is a `proven' precedent for what i am saying Bryan! Quote:
" Expression of p45 reappeared 12 h after release from contact inhibition and 6-8 h after release from TGF-beta 1, while TGF-beta 1 prevented release from contact inhibition and maintained suppression of both p45 and cyclin D2. "
OF COURSE TGF-beta 1 "maintained suppression" of both p45 and cyclin D2, because THAT'S WHAT IT DOES, just like contact inhibition! :wink: You're trying to spin what they said into suggesting that contact inhibition somehow causes a permanent change in the response of the cells to androgens, just because of that possible common pathway. But they neither said nor implied any such thing! They merely said that if you keep supplying TGF-beta 1, then you will continue to have suppression of p45 and cyclin D2, even after the contact inhibition has stopped.
Do you understand now?
Bryan